CAC 40
7 135,06 +18,82 (+0,26 %) Euro Stoxx 50
4 174,66 +13,10 (+0,31 %) Dow Jones
33 432,53 -233,81 (-0,69 %) EUR/USD
1,0573 +0,0006 (+0,05 %) Gold future
1 866,10 -12,50 (-0,67 %) Bitcoin EUR
25 346,59 -395,03 (-1,53 %)
Gilead Sciences, Inc. (GILD)
| Clôture précédente | 75,42 |
| Ouverture | 75,51 |
| Offre | 74,76 x 1000 |
| Vente | 74,80 x 1200 |
| Var. jour | 74,58 - 75,75 |
| Sur 52 semaines | 61,45 - 89,74 |
| Volume | |
| Volume moyen | 5 471 366 |
| Cap. boursière | 93,202B |
| Bêta (mensuel sur 5 ans) | 0,39 |
| Rapport P/E (sur 12 mois) | 17,20 |
| BPA (sur 12 mois) | 4,35 |
| Date de bénéfices | 25 oct. 2023 - 30 oct. 2023 |
| Dividende et rendement à terme | 3,00 (3,98 %) |
| Date ex-dividende | 14 sept. 2023 |
| Objectif sur 1 an | 91,04 |
ACCESSWIREGilead Sciences: A Career Rooted in Championing Diversity and Inclusion: Jesse's Story
NORHAMPTON, MA / ACCESSWIRE / November 10, 2022 / Gilead Sciences While Jesse Garcia was growing up in Chicago's inner city, his parents didn't immediately turn to a doctor when someone in the family got sick. "We relied on traditional Latino ...
- ACCESSWIRE
Gilead's Path to Equitable Global COVID-19 Treatment Access
NORTHAMPTON, MA / ACCESSWIRE / November 2, 2022 / Gilead Sciences Since the beginning of the COVID-19 pandemic, Gilead's first-in-class antiviral was made available to more than 11 million patients globally- over 65% of whom live in low-and lower-middle-income ...
- ACCESSWIRE
Gilead Sciences: Metastatic Breast Cancer Advocate Urges Black People to Join Clinical Trials
In the spring of 2018, North Carolina native Stephanie Walker went to her first breast cancer conference and had a revelation that she refers to as her "coming-out party." She learned she had metastatic breast cancer three years earlier and although she was a retired hospice nurse, she faced the disease without any guidance from others who shared her experience.
